Risk factors for early pregnancy loss
Risk factors for early pregnancy loss
批准号:
9257438
负责人:
Jae-Wook Jeong
金额:
$32.16万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-04-10 至 2021-03-31
关键词:
ARID DomainAgeAnimal ModelB-LymphocytesCenters for Disease Control and Prevention (U.S.)ChromatinComplexDataDecidual Cell ReactionsDefectDiseaseESR1 geneEndometrialEndometrial CarcinomaEndometrial Stromal CellEndometriumEpithelialEpithelial Cell ProliferationEpitheliumEstrogensEtiologyEventFamilyFemaleFemale infertilityGene ActivationGene TargetingGenetic TranscriptionGrowthHealthHormonalHumanImpairmentInfertilityKnockout MiceLesionMediatingModelingMolecularMusMutant Strains MiceMutationNucleosomesOvarianOvarian CarcinomaPhytoestrogensPlayPregnancyPregnancy lossProgesterone ReceptorsProteinsResearchResearch DesignResistanceResveratrolRisk FactorsRoleSamplingSignal TransductionSpontaneous abortionSterilityTestingTherapeuticTissuesTranscriptional ActivationTranscriptional RegulationUterusWomanWorkXenograft Modelcostdesignendometriosisexperimental studyhuman tissueimplantationinnovationmembermouse modelnovel therapeuticspreclinical studypregnantpublic health relevancereproductiveresponseuterine receptivity
中文摘要
描述(申请人提供):根据疾控中心的数据,15-44岁的已婚妇女中有6%不育,12.1%的妇女在怀孕或怀孕到足月时表现出困难。20周前的妊娠丢失称为早孕丢失或流产。在已知的怀孕中,约有15%会发生这种情况。植入缺陷导致了75%以上的失败妊娠,这表明需要将研究重点放在了解子宫容受性和成功植入所必需的复杂机制上。富含AT相互作用结构域的蛋白1A(ARID1A)是SWI/SNF家族的一员,在转录水平上激活通常被染色质抑制的基因是必需的。ARID1a缺失是子宫内膜癌和子宫内膜异位症相关卵巢癌的常见事件。然而,对ARID1A突变的病理生理效应的了解仍然很少,而且ARID1A在女性生殖轨道中的功能仍然难以捉摸。在我们的研究中,ARID1A丢失与子宫内膜异位症不孕妇女有关。此外,子宫特异性ARID1A基因敲除小鼠由于着床和蜕膜缺陷而不育。在突变小鼠的围着床期,E2信号和上皮细胞的增殖显著增加。在突变小鼠中,上皮PGR及其靶基因的水平下调。在这些数据的基础上,我们推测ARID1A通过抑制ESR1活性和增强PGR活性在着床和蜕膜形成过程中发挥重要作用。一种创新的治疗策略将是利用小鼠动物模型和人类子宫内膜异位症样本进行临床前研究,旨在阻止异常的上皮细胞增殖,并克服不孕症患者蜕膜受损的问题。
英文摘要
DESCRIPTION (provided by applicant): According to the CDC, 6% of married women between the ages of 15-44 are infertile, and 12.1% of women display difficulties getting pregnant or carrying a pregnancy to term. The loss of pregnancy before 20 weeks is called early pregnancy loss or miscarriage. They occur in about 15% of known pregnancies. Implantation defects contribute to over 75% of failed pregnancies, suggesting a need to focus research efforts towards understanding the complex mechanisms necessary for uterine receptivity and successful implantation. AT-rich interactive domain-containing protein 1A (ARID1A) is a member of the SWI/SNF family and is required for transcriptional activation of genes normally repressed by chromatin. ARID1A loss is a frequent event in endometrial cancers and endometriosis-associated ovarian carcinomas. However, an understanding of the pathophysiological effects of ARID1A mutations remains quite poor and the function of ARID1A in the female reproductive track has remained elusive. In our studies, ARID1A loss is implicated in infertile women with endometriosis. Furthermore, uterine-specific Arid1a knock-out mice were sterile due to a defect of implantation and decidualization. E2 signaling and proliferation of epithelium were significantly increased at the peri-implantation period of the mutant mice. The levels of epithelial PGR and its target genes are downregulated in mutant mice. On the basis of all these data, we hypothesized that ARID1A plays an important role for implantation and decidualization by suppressing ESR1 activities and enhancing PGR activities. An innovative therapeutic strategy would be to conduct preclinical studies designed to block aberrant epithelial proliferation and overcome impaired decidualization in infertility using mouse animal models as well as human endometriosis samples.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of cholesterol biosynthesis in metastatic and recurrent endometrialcancer
-
批准号:10560609
-
项目类别:
-
资助金额:$54.09万
-
财政年份:2022
-
负责人:Jae-Wook Jeong
-
依托单位:
Molecular mechanisms of endometrial progesterone resistance
-
批准号:10618181
-
项目类别:
-
资助金额:$51.47万
-
财政年份:2022
-
负责人:Jae-Wook Jeong
-
依托单位:
Development of anti-inflammatory nanodrug for endometriosis treatment
-
批准号:10709492
-
项目类别:
-
资助金额:$62.86万
-
财政年份:2022
-
负责人:Jae-Wook Jeong
-
依托单位:
The role of cholesterol biosynthesis in metastatic and recurrent endometrial cancer
-
批准号:10467152
-
项目类别:
-
资助金额:$25.49万
-
财政年份:2022
-
负责人:Jae-Wook Jeong
-
依托单位:
The role of cholesterol biosynthesis in metastatic and recurrent endometrialcancer
-
批准号:10661912
-
项目类别:
-
资助金额:$32.92万
-
财政年份:2022
-
负责人:Jae-Wook Jeong
-
依托单位:
Epigenetic regulation of receptive endometrium
-
批准号:10674101
-
项目类别:
-
资助金额:$43.0万
-
财政年份:2022
-
负责人:Jae-Wook Jeong
-
依托单位:
Epigenetic regulation of receptive endometrium
-
批准号:10551346
-
项目类别:
-
资助金额:$58.72万
-
财政年份:2022
-
负责人:Jae-Wook Jeong
-
依托单位:
Molecular mechanisms of endometrial progesterone resistance
-
批准号:10662676
-
项目类别:
-
资助金额:$46.95万
-
财政年份:2022
-
负责人:Jae-Wook Jeong
-
依托单位:
Epigenetic regulation of receptive endometrium
-
批准号:10390408
-
项目类别:
-
资助金额:$16.12万
-
财政年份:2021
-
负责人:Jae-Wook Jeong
-
依托单位:
SIRT1 as a Therapeutic Target in Endometriosis
-
批准号:10309093
-
项目类别:
-
资助金额:$38.58万
-
财政年份:2021
-
负责人:Jae-Wook Jeong
-
依托单位:
Epigenetic regulation of receptive endometrium
-
批准号:10231662
-
项目类别:
-
资助金额:$60.68万
-
财政年份:2021
-
负责人:Jae-Wook Jeong
-
依托单位:
SIRT1 as a Therapeutic Target in Endometriosis
-
批准号:10700024
-
项目类别:
-
资助金额:$42.47万
-
财政年份:2021
-
负责人:Jae-Wook Jeong
-
依托单位:
SIRT1 as a Therapeutic Target in Endometriosis
-
批准号:10474480
-
项目类别:
-
资助金额:$35.83万
-
财政年份:2021
-
负责人:Jae-Wook Jeong
-
依托单位:
Molecular mechanisms of endometrial progesterone resistance
-
批准号:10393011
-
项目类别:
-
资助金额:$4.52万
-
财政年份:2020
-
负责人:Jae-Wook Jeong
-
依托单位:
Molecular mechanisms of endometrial progesterone resistance
-
批准号:10229616
-
项目类别:
-
资助金额:$51.47万
-
财政年份:2020
-
负责人:Jae-Wook Jeong
-
依托单位:
Risk factors for early pregnancy loss
-
批准号:9111405
-
项目类别:
-
资助金额:$32.08万
-
财政年份:2016
-
负责人:Jae-Wook Jeong
-
依托单位:
Steroid Hormone Regulation of Uterine Function and Dysfunction
-
批准号:8097062
-
项目类别:
-
资助金额:$3.28万
-
财政年份:2010
-
负责人:Jae-Wook Jeong
-
依托单位:
Steroid Hormone Regulation of Uterine Function and Dysfunction
-
批准号:7609077
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2008
-
负责人:Jae-Wook Jeong
-
依托单位:
Steroid Hormone Regulation of Uterine Function and Dysfunction
-
批准号:8059736
-
项目类别:
-
资助金额:$24.8万
-
财政年份:2008
-
负责人:Jae-Wook Jeong
-
依托单位:
Steroid Hormone Regulation of Uterine Function and Dysfunction
-
批准号:8249345
-
项目类别:
-
资助金额:$24.8万
-
财政年份:2008
-
负责人:Jae-Wook Jeong
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: